Spectral Medical Inc's stock has seen a modest decline this week amid significant corporate developments.
As of the latest trading session, Spectral Med Inc (EDT.TO) closed at C$1.27, reflecting a 0.76% drop for the day and a 3.70% decrease over the past week. The company, which operates in the healthcare sector, is navigating a series of financial adjustments and clinical milestones that may impact its future performance.
Advertisement
Spectral Med Inc
EDT.TO
EDT.TO
Spectral Med Inc
WealthAwesomeMarket cap
$325.84M
52W high
$1.65
52W low
$1.03
1W change
-5.53%
Beta
0.22
Analyst Price Targets
Based on analyst covering EDT · as of Sep 17, 2026
Wall Street analysts forecast EDT stock price to rise 183.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.15
+183.8% Upside
Current Price
C$1.11
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EDT's historical volatility
30-Day Vol
50.5%
Annualized
90-Day Vol
37.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.93
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$1.05 | C$0.88 – C$1.25 |
| 60 trading days | C$0.99 | C$0.77 – C$1.26 |
| 90 trading days | C$0.93 | C$0.69 – C$1.26 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should remain cautious as Spectral Medical's stock continues to trade below its moving averages, despite a promising outlook from analysts. The company's recent financial activities and regulatory progress could be pivotal, but potential risks remain.
C$1.27
Spectral Medical's stock closed down 0.76% on the day, continuing a trend of declines over the past week and month.
Bull case
Analysts are optimistic about Spectral Medical, with an average target price of C$3.15, indicating significant upside potential. The recent completion of the U.S. FDA Premarket Approval application for PMX could boost market confidence.
Bear case
Despite the positive sentiment from analysts, the stock's performance has been disappointing, and its current trading levels are below key moving averages. The company also faces challenges with a negative return on equity and a profit margin of 0.0%.
Recent Price Action
Advertisement
Spectral Medical Inc's stock has experienced a decline, closing at C$1.27, representing a 0.76% decrease for the day and a 3.70% drop for the week. Over the past month, the stock has decreased by 6.47%, and year-to-date, it is down 5.80%. The trading volume for the latest session was 49,358 shares, which is 1.29 times the 20-day average volume of 56,105 shares.
Company News and Developments
While no major news was released this week, recent developments include the announcement of financial results for Q2 2026, where Spectral Medical highlighted the completion of its U.S. FDA Premarket Approval application for PMX. The company also secured a US$3 million advance from Vantive US Healthcare LLC, strengthening its financial position for ongoing regulatory preparations.
Technical Picture
From a technical standpoint, Spectral Medical's stock is currently trading below its 50-day moving average of C$1.36 and its 200-day moving average of C$1.35, indicating a bearish trend. The stock's 52-week range is C$1.21 to C$1.76, with the current price at 11% of this range. The stock's beta is 0.21, suggesting lower volatility compared to the broader market.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
